Президентът на КРИБ Кирил Домусчиев изрази задоволството си от факта, че компанията му е пред финализиране на сделка за закупуване на авторитетната американска компания "Агрилабс", която е водеща в областта на производството на ветеринарно-медицински продукти.

Ето какво написа Домусчиев в социалната мрежа:

Изключително съм горд с постигнатото през годините от "Хювефарма"! Компания, която стартира от нищото! Сделката от днес за покупката на американските Agrilabs и Benchmark Bios ще открие нови хоризонти за нас. Благодаря на всички колеги от САЩ и България, които участваха в процеса на преговорите и due diligence! Трябва да продължим да сбъдваме мечтите си и да славим българското по света!

Huvepharma® Acquires AgriLabs®
Purchase will expand U.S. presence, speed commercialization of animal health innovations

PEACHTREE CITY, GEORGIA – January 5, 2018 – Huvepharma® today announced its acquisition of AgriLabs® in a move that will expand the U.S. presence of the global animal health and nutrition company and speed commercialization of their biologic solutions for animal health.

“We’re very excited about the talent and technology that are part of the AgriLabs businesses,” says Glen Wilkinson, president of Huvepharma, USA. “This acquisition furthers Huvepharma’s strategy in creating a balanced portfolio of products and enhancing our presence in the global market. It also enables more rapid commercialization of biological products through Benchmark Biolabs, a subsidiary of AgriLabs and part of the acquisition of companies.”

“We’re pleased to be a part of Huvepharma’s global animal health company as this acquisition will provide resources to bring new solutions to veterinarians and producers more quickly.” It will also allow us to accelerate the development of the ExactVac DNA vaccine with ENABL adjuvant which represents the next generation of biological innovation in animal health, says Steve Schram, president and CEO of AgriLabs.

The acquisition includes AgriLabs product lines including Colostrx® CS and Colostrx® CR; I-Site® XP, MpB Guard® and Pulmo-Guard® PH-M vaccines; the VetGunTM insecticide delivery system; and AgriLabs’ custom vaccines business. In addition, the acquisition also includes Antelope Valley Bios, a contract manufacturing business; and the VaxLiant® portfolio of novel adjuvants – all based in Lincoln, Nebraska.

Both companies will continue operations under their current identities as integration opportunities are identified in 2018.

“Huvepharma and AgriLabs are strong, complementary businesses focused on providing real solutions for the animal food producing industry,” Wilkinson says. “This acquisition only strengthens our ability to provide the highest quality products and services as Huvepharma’s commitment to serving our customers.”

###

About Huvepharma: Huvepharma® is a global pharmaceutical company with a focus on developing, manufacturing and marketing of human and animal health products. Huvepharma is a privately-owned company, headquartered in Sofia, Bulgaria. Its U.S. headquarters are in Peachtree City, Georgia.

About AgriLabs: AgriLabs®, based in St. Joseph, Missouri, is a leader in biological innovation for animal health in the United States. Through proprietary DNA and adjuvant technologies – combined with other innovative products, AgriLabs is delivering the next generation of animal health solutions for farm animals.